Brian Abrahams
Recent Articles about Cidara Therapeutics Inc.
Pharma's Flu Drug Could Be Worth Billions, Analyst Says 09/29/2025
Cidara Therapeutics Inc. (CDTX:NASDAQ) shares the minutes from an important meeting with the FDA, and the overall feedback was encouraging. Find out what one analyst predicts that will mean for Phase III development.
© 2025 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
